We are live on ! Find out more
ATRS

Antares Pharma, Inc.

Delisted

ATRS was delisted on the 23rd of May, 2022.

87 hedge funds and large institutions have $190M invested in Antares Pharma, Inc. in 2013 Q2 according to their latest regulatory filings, with 87 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

70% less call options, than puts

Call options by funds: $650K | Put options by funds: $2.17M

Holders
87
Holders Change
+87
Holders Change %
% of All Funds
2.84%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
87
Increased
Reduced
Closed
Calls
$650K
Puts
$2.17M
Net Calls
-$1.52M
Net Calls Change
-$1.52M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change
Change in
Stake
Ameriprise
76
Ameriprise
Minnesota
$29K +$27.1K +7,027 New
Barclays
77
Barclays
United Kingdom
$24K +$22.5K +5,831 New
Royal Bank of Canada
78
Royal Bank of Canada
Ontario, Canada
$22K +$20.3K +5,250 New
BlackRock
79
BlackRock
New York
$21K +$19.5K +5,046 New
BG
80
BlackRock Group
United Kingdom
$11K +$10K +2,596 New
Creative Planning
81
Creative Planning
Kansas
$11K +$10.4K +2,700 New
Bank of Montreal
82
Bank of Montreal
Ontario, Canada
$10K +$9.17K +2,375 New
BWM
83
Baystate Wealth Management
Massachusetts
$6K +$5.4K +1,397 New
DADC
84
D.A. Davidson & Co
Montana
$4K +$3.86K +1,000 New
LTFS
85
Ladenburg Thalmann Financial Services
Florida
$2K +$1.93K +500 New
PG
86
PEAK6 Group
Illinois
$162 +$150K +38,900 New
CD
87
Carl Domino
Florida
+$146K +37,820 New

ATRS Hedge Fund Activity: Q2 2013 in Review

87 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Antares Pharma, Inc. (ATRS) for Q2 2013, worth a combined $190M.

Buyers outnumbered sellers: 87 funds opened new ATRS positions and 0 closed out — a net gain of 87 holders — while 0 added to existing stakes and 0 trimmed.

  • 87 institutional investors held Antares Pharma, Inc. (ATRS) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $190M of Antares Pharma, Inc. stock for Q2 2013.
  • 87 funds opened new Antares Pharma, Inc. positions in Q2 2013 and 0 closed out, a net change of +87 holders.

Based on aggregated 13F filings for Q2 2013.